CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...

GSK's Blenrep approved in the U.K. for multiple myeloma after strong phase 3 data showing improved survival in DREAMM-7 and ...

GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Nifty surged 4.5% this week to 23,852, its biggest weekly gain since Feb 2021. HDFC Bank, ICICI Bank, Bharti Airtel and Bajaj ...

GSK plc (LSE/NYSE: GSK) today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has voted to recommend use of PENMENVY ...

Euro US Dollar, British Pound US Dollar, FTSE 100, Taylor Wimpey PLC. Read 's Market Analysis on Investing.com ...

LVMH lost its position on Tuesday as Europe's largest luxury company in terms of market capitalization after being overtaken by rival Hermes due to investor pessimism after disappointing first-quarter ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.